ATE197800T1 - Dns kodierend für einen für epithelzellen spezifischen wachstumsfaktor - Google Patents

Dns kodierend für einen für epithelzellen spezifischen wachstumsfaktor

Info

Publication number: ATE197800T1
Authority: AT; Austria
Prior art keywords: cells; growth factor; protein; kgf; epithelial cells
Prior art date: 1989-01-31

Application number

AT90903253T

Other languages

English (en)

Inventor

Jeffrey S Rubin

Paul W Finch

Stuart A Aaronson

Original Assignee

Jeffrey S Rubin

Paul W Finch

Stuart A Aaronson

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-01-31

Filing date

1990-01-30

Publication date

2000-12-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23175833&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE197800(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-01-30 Application filed by Jeffrey S Rubin, Paul W Finch, Stuart A Aaronson filed Critical Jeffrey S Rubin

2000-12-15 Application granted granted Critical

2000-12-15 Publication of ATE197800T1 publication Critical patent/ATE197800T1/de

Links

210000002919 epithelial cell Anatomy 0.000 title 1
239000003102 growth factor Substances 0.000 title 1
108090000623 proteins and genes Proteins 0.000 abstract 4
210000004027 cell Anatomy 0.000 abstract 3
102000004169 proteins and genes Human genes 0.000 abstract 3
102000003972 Fibroblast growth factor 7 Human genes 0.000 abstract 2
108090000385 Fibroblast growth factor 7 Proteins 0.000 abstract 2
108020004414 DNA Proteins 0.000 abstract 1
101001060261 Homo sapiens Fibroblast growth factor 7 Proteins 0.000 abstract 1
108020004511 Recombinant DNA Proteins 0.000 abstract 1
239000000427 antigen Substances 0.000 abstract 1
102000036639 antigens Human genes 0.000 abstract 1
108091007433 antigens Proteins 0.000 abstract 1
210000001124 body fluid Anatomy 0.000 abstract 1
239000010839 body fluid Substances 0.000 abstract 1
210000003722 extracellular fluid Anatomy 0.000 abstract 1
102000057239 human FGF7 Human genes 0.000 abstract 1
108020004999 messenger RNA Proteins 0.000 abstract 1
229920001184 polypeptide Polymers 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
230000003248 secreting effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C07K14/501—Fibroblast growth factor [FGF] acidic FGF [aFGF]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Immunology (AREA)
Toxicology (AREA)
Analytical Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Dermatology (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)

AT90903253T 1989-01-31 1990-01-30 Dns kodierend für einen für epithelzellen spezifischen wachstumsfaktor ATE197800T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US30428189A	1989-01-31	1989-01-31
PCT/US1990/000418 WO1990008771A1 (en)	1989-01-31	1990-01-30	Dna encoding a growth factor specific for epithelial cells

Publications (1)

Publication Number	Publication Date
ATE197800T1 true ATE197800T1 (de)	2000-12-15

Family

ID=23175833

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90903253T ATE197800T1 (de)	1989-01-31	1990-01-30	Dns kodierend für einen für epithelzellen spezifischen wachstumsfaktor

Country Status (22)

Country	Link
US (8)	US6420531B1 (de)
EP (2)	EP0555205B1 (de)
JP (6)	JP3298874B2 (de)
KR (1)	KR950012805B1 (de)
AT (1)	ATE197800T1 (de)
AU (2)	AU647732B2 (de)
CA (2)	CA2349875C (de)
DE (2)	DE69033668T2 (de)
DK (1)	DK0555205T3 (de)
ES (1)	ES2153816T3 (de)
FI (1)	FI114711B (de)
GE (1)	GEP20022681B (de)
HU (1)	HU218090B (de)
IE (1)	IE20020188A1 (de)
LT (1)	LT3472B (de)
LU (1)	LU91237I2 (de)
LV (1)	LV10284B (de)
NL (1)	NL300230I2 (de)
NO (2)	NO308312B1 (de)
RU (1)	RU2250213C2 (de)
SG (1)	SG46699A1 (de)
WO (1)	WO1990008771A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE197800T1 (de)	1989-01-31	2000-12-15	Jeffrey S Rubin	Dns kodierend für einen für epithelzellen spezifischen wachstumsfaktor
GB9203533D0 (en) *	1992-02-19	1992-04-08	Erba Carlo Spa	Use of the conjugate between a fibroblast growth factor and a saporin in treating ocular pathologies
US5965530A (en) *	1993-03-26	1999-10-12	Amgen Inc.	Therapeutic uses of keratinocyte growth factor
KR100390340B1 (ko) *	1993-03-26	2003-09-26	암겐 인코포레이티드	케라티노사이트성장인자산물을함유하는제약학적조성물
ES2227527T3 (es) *	1993-06-29	2005-04-01	Chiron Corp	Un factor de crecimiento de queratinocitos (kgf) truncado que tiene actividad biologica aumentada.
US7084119B2 (en)	1993-06-29	2006-08-01	Chiron Corporation	Truncated keratinocyte growth factor (KGF) having increased biological activity
US6268212B1 (en)	1993-10-18	2001-07-31	Amgen Inc.	Tissue specific transgene expression
WO1996011951A2 (en) *	1994-10-13	1996-04-25	Amgen Inc.	Keratinocyte growth factor analogs
US6008328A (en) *	1994-10-13	1999-12-28	Amgen Inc.	Method for purifying keratinocyte growth factors
CZ98297A3 (cs) *	1994-10-13	1998-08-12	Amgen Inc.	Způsob purifikace keratinocytových růstových faktorů
SK284534B6 (sk) *	1994-10-13	2005-06-02	Amgen Inc.	Polypeptidový analóg natívneho keratinocytového rastového faktora, spôsob jeho výroby a použitie, farmaceutický prostriedok a kit, nukleová kyselina, vektor a hostiteľská bunka
US6818439B1 (en)	1994-12-30	2004-11-16	Chiron Corporation	Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia and other disorders
US6030613A (en)	1995-01-17	2000-02-29	The Brigham And Women's Hospital, Inc.	Receptor specific transepithelial transport of therapeutics
US7232667B2 (en)	1995-02-14	2007-06-19	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 polynucleotides
US6077692A (en)	1995-02-14	2000-06-20	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
US6693077B1 (en)	1995-02-14	2004-02-17	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
DK1486565T3 (da)	1995-10-11	2008-03-10	Novartis Vaccines & Diagnostic	Kombination af PDGF, KGF, IGF og IGFBP til sårheling
US6692961B1 (en)	1996-10-11	2004-02-17	Invitrogen Corporation	Defined systems for epithelial cell culture and use thereof
US20030144202A1 (en) *	1996-10-15	2003-07-31	Amgen Inc.	Uses of keratinocyte growth factor-2
US6743422B1 (en)	1996-10-15	2004-06-01	Amgen, Inc.	Keratinocyte growth factor-2 products
DE19716098A1 (de) *	1997-04-17	1998-10-22	Univ Ludwigs Albert	Fibroblasten mit einem Fremdgen enthaltende Zusammensetzung zur Behandlung von Wunden
US6228839B1 (en)	1997-12-19	2001-05-08	Emory University	Use of keratinocyte growth factor to improve oxidative status
US6869927B1 (en)	1997-12-22	2005-03-22	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 formulations
EP1041996A4 (de)	1997-12-22	2003-05-14	Human Genome Sciences Inc	Keratinozyten wachstumsfaktor-2 formulierungen
CA2320515A1 (en) *	1998-02-13	1999-08-19	Human Genome Sciences, Inc.	Therapeutic uses of keratinocyte growth factor-2
US6335317B1 (en)	1998-04-10	2002-01-01	Emory University	Use of gut-trophic growth factors to improve oxidative status
US7022683B1 (en)	1998-05-13	2006-04-04	Carrington Laboratories, Inc.	Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US5929051A (en) *	1998-05-13	1999-07-27	Carrington Laboratories, Inc.	Aloe pectins
US6313103B1 (en)	1998-05-13	2001-11-06	Carrington Laboratories, Inc.	Pectic substance as a growth factor stabilizer
US6372494B1 (en) *	1999-05-14	2002-04-16	Advanced Tissue Sciences, Inc.	Methods of making conditioned cell culture medium compositions
US6371984B1 (en) *	1999-09-13	2002-04-16	Keraplast Technologies, Ltd.	Implantable prosthetic or tissue expanding device
US6783546B2 (en)	1999-09-13	2004-08-31	Keraplast Technologies, Ltd.	Implantable prosthetic or tissue expanding device
US6395414B1 (en)	2000-02-11	2002-05-28	General Motors Corporation	Staged venting of fuel cell system during rapid shutdown
US6376112B1 (en)	2000-02-11	2002-04-23	General Motors Corporation	Controlled shutdown of a fuel cell
US6413662B1 (en)	2000-02-22	2002-07-02	General Motors Corporation	Fuel cell system shutdown with anode pressure control
JP2001302691A (ja) *	2000-04-17	2001-10-31	Nichirei Corp	ヒトｋｇｆに対する抗体
US20030186904A1 (en) *	2001-01-08	2003-10-02	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
HUP0303199A2 (hu)	2001-02-19	2003-12-29	Merck Patent Gmbh	Eljárás T-sejt-epitópok azonosítására és csökkentett immunogenitású molekulák előállítására
US7494669B2 (en)	2001-02-28	2009-02-24	Carrington Laboratories, Inc.	Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
MXPA04001526A (es) *	2001-08-21	2004-05-31	Chiron Corp	Composiciones de polipetidos kgf.
US7202066B2 (en) *	2002-01-29	2007-04-10	Carrington Laboratories, Inc.	Combination of a growth factor and a protease enzyme
GB0206309D0 (en) *	2002-03-16	2002-05-01	Axordia Ltd	Isolated cells
US20050074773A1 (en) *	2002-08-20	2005-04-07	Shimkets Richard A.	Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals
BRPI0519070A2 (pt)	2004-12-15	2008-12-23	Amgen Inc	composiÇço de fator de crescimento de queratinàcito liofilizada, mÉtodos para preparar um fator de crescimento de queratinàcito liofilizado, e para tratar uma doenÇa, e, kit para preparar uma composiÇço farmacÊutica aquosa
US20080119433A1 (en) *	2006-07-06	2008-05-22	Aaron Thomas Tabor	Compositions and Methods for Genetic Modification of Cells Having Cosmetic Function to Enhance Cosmetic Appearance
AU2007342353B2 (en) *	2007-01-05	2012-06-28	Helix Biomedix Inc.	Short bio-active peptides for cellular and immunological modulation
CN102471769A (zh) *	2009-07-17	2012-05-23	亚伦·T.·塔波尔	用于具有美容功能的细胞的遗传修饰以提高美容外观的方法和组合物
EP2875359A4 (de)	2012-03-30	2015-08-19	Charles R Drew University Of Medicine And Science	Zusammensetzungen und verfahren zur behandlung oder prävention von stoffwechselsyndromerkrankungen
KR102277147B1 (ko) *	2017-12-13	2021-07-13	건국대학교 산학협력단	섬유아 성장인자 유래 펩타이드의 골 또는 연골 분화 촉진 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5096825A (en) *	1983-01-12	1992-03-17	Chiron Corporation	Gene for human epidermal growth factor and synthesis and expression thereof
US4444760A (en) *	1983-06-17	1984-04-24	Merck & Co., Inc.	Purification and characterization of a protein fibroblast growth factor
US4473679A (en)	1983-12-12	1984-09-25	Borg-Warner Chemicals, Inc.	Thermoplastic acrylic elastomers
US4743679A (en) *	1986-02-24	1988-05-10	Creative Biomolecules, Inc.	Process for producing human epidermal growth factor and analogs thereof
US4868113A (en)	1986-03-03	1989-09-19	Rorer Biotechnology, Inc.	Recombinant DNA vector encoding human endothelial cell growth factor
US4983679A (en)	1986-05-29	1991-01-08	E. I. Dupont De Nemours And Company	β-(keto or sulfonyl)esters from reaction of silylketene acetal and acyl or sulfonyl compound
IL89661A (en)	1988-03-17	1999-05-09	Novo Nordisk As	Heparin binding proteins
ATE197800T1 (de)	1989-01-31	2000-12-15	Jeffrey S Rubin	Dns kodierend für einen für epithelzellen spezifischen wachstumsfaktor
ES2227527T3 (es) *	1993-06-29	2005-04-01	Chiron Corp	Un factor de crecimiento de queratinocitos (kgf) truncado que tiene actividad biologica aumentada.
SK284534B6 (sk)	1994-10-13	2005-06-02	Amgen Inc.	Polypeptidový analóg natívneho keratinocytového rastového faktora, spôsob jeho výroby a použitie, farmaceutický prostriedok a kit, nukleová kyselina, vektor a hostiteľská bunka

1990
- 1990-01-30 AT AT90903253T patent/ATE197800T1/de active
- 1990-01-30 DE DE69033668T patent/DE69033668T2/de not_active Expired - Lifetime
- 1990-01-30 RU SU5001740/13A patent/RU2250213C2/ru active
- 1990-01-30 WO PCT/US1990/000418 patent/WO1990008771A1/en active IP Right Grant
- 1990-01-30 HU HU998/90A patent/HU218090B/hu unknown
- 1990-01-30 DK DK90903253T patent/DK0555205T3/da active
- 1990-01-30 SG SG1996008633A patent/SG46699A1/en unknown
- 1990-01-30 EP EP90903253A patent/EP0555205B1/de not_active Expired - Lifetime
- 1990-01-30 ES ES90903253T patent/ES2153816T3/es not_active Expired - Lifetime
- 1990-01-30 EP EP00103140A patent/EP1016716A3/de not_active Withdrawn
- 1990-01-30 AU AU50496/90A patent/AU647732B2/en not_active Expired
- 1990-01-30 GE GEAP1990983A patent/GEP20022681B/en unknown
- 1990-01-30 JP JP50341390A patent/JP3298874B2/ja not_active Expired - Lifetime
- 1990-01-31 IE IE20020188A patent/IE20020188A1/en not_active Application Discontinuation
- 1990-09-29 KR KR90702202A patent/KR950012805B1/ko not_active IP Right Cessation
1991
- 1991-03-15 CA CA2349875A patent/CA2349875C/en not_active Expired - Lifetime
- 1991-03-15 CA CA002038398A patent/CA2038398C/en not_active Expired - Lifetime
- 1991-07-30 FI FI913637A patent/FI114711B/fi active
1992
- 1992-12-23 LV LVP-92-410A patent/LV10284B/xx unknown
1993
- 1993-06-21 LT LTIP667A patent/LT3472B/lt not_active IP Right Cessation
1994
- 1994-06-28 AU AU65986/94A patent/AU684278B2/en not_active Expired
1995
- 1995-05-31 US US08/455,620 patent/US6420531B1/en not_active Expired - Lifetime
- 1995-05-31 US US08/455,628 patent/US5665870A/en not_active Expired - Lifetime
- 1995-05-31 US US08/455,641 patent/US5707805A/en not_active Expired - Lifetime
- 1995-05-31 US US08/455,975 patent/US6833132B1/en not_active Expired - Lifetime
- 1995-05-31 US US08/455,655 patent/US5654405A/en not_active Expired - Lifetime
- 1995-05-31 US US08/455,672 patent/US5741642A/en not_active Expired - Lifetime
- 1995-06-07 US US08/480,948 patent/US5731170A/en not_active Expired - Lifetime
- 1995-06-07 US US08/477,982 patent/US6709842B1/en not_active Expired - Lifetime
- 1995-12-27 JP JP7341890A patent/JP2716416B2/ja not_active Expired - Lifetime
1997
- 1997-05-16 NO NO972259A patent/NO308312B1/no not_active IP Right Cessation
- 1997-06-06 NO NO972617A patent/NO308310B1/no not_active IP Right Cessation
- 1997-10-22 JP JP09290175A patent/JP3088983B2/ja not_active Expired - Lifetime
1999
- 1999-10-06 JP JP28551799A patent/JP3802292B2/ja not_active Expired - Lifetime
2000
- 2000-10-11 JP JP2000311208A patent/JP3802329B2/ja not_active Expired - Lifetime
2006
- 2006-03-06 JP JP2006060217A patent/JP2006149407A/ja not_active Withdrawn
- 2006-04-11 DE DE200612000021 patent/DE122006000021I1/de active Pending
- 2006-04-19 NL NL300230C patent/NL300230I2/nl unknown
- 2006-04-24 LU LU91237C patent/LU91237I2/fr unknown

Also Published As

Publication number	Publication date
JP3802292B2 (ja)	2006-07-26
EP0555205B1 (de)	2000-11-29
US6420531B1 (en)	2002-07-16
US5654405A (en)	1997-08-05
HU218090B (hu)	2000-05-28
CA2349875A1 (en)	1992-09-16
US5741642A (en)	1998-04-21
LTIP667A (en)	1995-01-31
FI114711B (fi)	2004-12-15
US6709842B1 (en)	2004-03-23
JPH04504415A (ja)	1992-08-06
LV10284A (lv)	1994-10-20
JP3088983B2 (ja)	2000-09-18
GEP20022681B (en)	2002-04-25
JP3802329B2 (ja)	2006-07-26
CA2038398A1 (en)	1992-09-16
NL300230I1 (nl)	2006-07-03
NO308312B1 (no)	2000-08-28
EP1016716A2 (de)	2000-07-05
NO308310B1 (no)	2000-08-28
AU684278B2 (en)	1997-12-11
AU6598694A (en)	1994-09-08
CA2038398C (en)	2002-01-22
NO972617L (no)	1997-06-06
JP2001157594A (ja)	2001-06-12
NO972617D0 (no)	1997-06-06
DE122006000021I1 (de)	2006-07-13
LV10284B (en)	1995-04-20
US6833132B1 (en)	2004-12-21
JP2006149407A (ja)	2006-06-15
EP1016716A3 (de)	2000-07-12
WO1990008771A1 (en)	1990-08-09
US5665870A (en)	1997-09-09
EP0555205A1 (de)	1993-08-18
LU91237I2 (fr)	2007-02-22
NL300230I2 (nl)	2006-09-01
AU5049690A (en)	1990-08-24
JP2716416B2 (ja)	1998-02-18
HUT58759A (en)	1992-03-30
DE69033668D1 (de)	2001-01-04
DE69033668T2 (de)	2001-04-12
LT3472B (en)	1995-10-25
AU647732B2 (en)	1994-03-31
US5707805A (en)	1998-01-13
KR950012805B1 (en)	1995-10-21
JPH08277227A (ja)	1996-10-22
KR910700257A (ko)	1991-03-14
CA2349875C (en)	2010-02-09
IE20020188A1 (en)	2002-06-26
EP0555205A4 (de)	1992-06-02
FI913637A0 (fi)	1991-07-30
NO972259L (no)	1997-05-16
SG46699A1 (en)	1998-02-20
RU2250213C2 (ru)	2005-04-20
NO972259D0 (no)	1997-05-16
DK0555205T3 (da)	2001-03-05
JP3298874B2 (ja)	2002-07-08
JPH10243800A (ja)	1998-09-14
US5731170A (en)	1998-03-24
JP2000102396A (ja)	2000-04-11
ES2153816T3 (es)	2001-03-16

Publication	Publication Date	Title
ATE197800T1 (de)	2000-12-15	Dns kodierend für einen für epithelzellen spezifischen wachstumsfaktor
NO963371L (no)	1996-10-11	Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det
CA2413857A1 (en)	2002-01-03	Pd-l2 molecules: pd-1 ligands and uses therefor
ATE135371T1 (de)	1996-03-15	Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
PT101297A (pt)	1994-06-30	Factores mitogenicos gliais, sua preparacao e utilizacao
PT87138A (pt)	1988-04-01	Process for the preparation of adn recombinant molecules codin g polypeptide adn segments and of antibody compositions relate d with human tissue factor
FI820075L (fi)	1982-07-17	Rekombination-dna-medel och foerfarande
DE3881776D1 (de)	1993-07-22	Dns-konstruktionen, enthaltend eine kluyveromyces-alpha-factor-leadersequenz zur leitung der sekretion von heterologen polypeptiden.
DE68929043T2 (de)	2000-04-13	Für androgen-rezeptor-protein kodierende dna
HUP0002472A2 (hu)	2000-10-28	Izolált dendritikus sejtmembrán-fehérje gének
DE60144021D1 (de)	2011-03-24	Für zellzyklusproteine kodierende nukleinsäure und deren verwendung
DK0535150T3 (da)	1995-05-15	Humant makrofag-inflammatorisk protein-2-beta
EP0286147A3 (de)	1990-05-16	Insulin-bindende Peptide und deren Verwendung
DE3853955D1 (de)	1995-07-13	Ein gen, das für glukuronidpermeas kodiert.
ATE335005T1 (de)	2006-08-15	Menschliches protein mit in vitro antiproliferativer aktivität.
ATE124722T1 (de)	1995-07-15	Für das plazentaprotein 9 (pp9) kodierende cdna, ihre isolierung und verwendung.